Genomics Market

Table of Content

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Introduction

2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Hospitals

2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach

3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis

3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation

3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Genomics
6.2.1. Key Characteristics of Genomics
6.2.2. Key Applications of the Genomics
6.2.3. Challenges Associated with Genomics

6.3. Future Perspective

7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. Genomics: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size

7.2.3. Genomics: Overall Market Landscape
7.2.3.1. Analysis by Deliverable Type
7.2.3.2. Analysis by Technology Type
7.2.3.3. Analysis by Process Type
7.2.3.4. Analysis by Study Type
7.2.3.5. Analysis by Application Type
7.2.3.6. Analysis by End Users

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies

8.4. Company Competitiveness Analysis: Genomics
8.4.1. Genomics Based in North America (Peer Group 1)
8.4.2. Genomics Based in Europe (Peer Group 2)
8.4.3. Genomics Based in Asia-Pacific (Peer Group 3)
8.4.4. Genomics Based in Middle East and North Africa, and Latin America (Peer Group 4)

8.5. Key Findings

9. COMPANY PROFILES
9.1. Chapter Overview
9.2. 23andMe
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook

* Similar detail is presented for other below mentioned companies based on information in the public domain

9.3. Agilent Technologies
9.4. Bio-Rad Laboratories
9.5. BGI Genomics
9.6. Color Genomics
9.7. Danaher
9.8. Eppendorf
9.9. Eurofins Scientific
9.10. GE Healthcare
9.11. Illumina
9.12. Myriad Genetics
9.13. Oxford Nanopore Technologies
9.14. Pacific Biosciences of California
9.15. QIAGEN
9.16. Quest Diagnostics
9.17. Thermo Fisher Scientific

10. SWOT ANALYSIS

11. MARKET IMPACT ANALYSIS
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL GENOMICS MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Trends Disruption Impacting Market
12.4. Global Genomics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

12.5. Multivariate Scenario Analysis
12.5.1. Conservative Scenario
12.5.2. Optimistic Scenario

12.6. Key Market Segmentations

13. MARKET OPPORTUNITIES BASED ON TYPE OF DELIVERABLE
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix

13.6. Genomics Market for Products: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.1. Genomics Market for Instruments / Systems / Software: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.2. Genomics Market for Consumables & Reagents: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

13.7. Genomics Market for Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.1. Genomics Market for NGS-Based Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.2. Genomics Market for Core Genomics Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.3. Genomics Market for Biomarker Translation Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.4. Genomics Market for Computational Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.5. Genomics Market for Other Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

13.8. Data Triangulation and Validation

14. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix
14.6. Genomics Market for Sequencing: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7. Genomics Market for Polymerase Chain Reaction: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.8. Genomics Market for Flow Cytometry: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.9. Genomics Market for Microarrays: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.10. Genomics Market for Other Technologies: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.11. Data Triangulation and Validation

15. MARKET OPPORTUNITIES BASED ON TYPE OF PROCESS
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix
15.6. Genomics Market for Library Preparation: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.7. Genomics Market for Data Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.8. Data Triangulation and Validation

16. MARKET OPPORTUNITIES BASED ON TYPE OF STUDY
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix

16.6. Genomics Market for Functional Genomics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.1. Genomics Market for Transfection: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.2. Genomics Market for Real-Time PCR: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.3. Genomics Market for RNA Interference: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.4. Genomics Market for Mutational Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.5. Genomics Market for SNP Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.6. Genomics Market for Microarray Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

16.7. Genomics Market for Epigenomics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7.1. Genomics Market for Bisulfite Sequencing: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7.2. Genomics Market for Chromatin Immunoprecipitation (ChIP & ChIP-Seq): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7.3. Genomics Market for Methylated DNA Immunoprecipitation (MeDIP): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7.4. Genomics Market for High-Resolution Melt (HRM): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7.5. Genomics Market for Chromatin Accessibility Assays : Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7.6. Genomics Market for Microarray Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

16.8. Genomics Market for Pathway Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.8.1. Genomics Market for Bead-Based Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.8.2. Genomics Market for Microarray Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.8.3. Genomics Market for Real-time PCR: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.8.4. Genomics Market for Proteomics Tools (2-D PAGE; yeast 2-hybrid studies): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

16.9. Genomics Market for Biomarker Discovery: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9.1. Genomics Market for Mass Spectrometry: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9.2. Genomics Market for Real-Time PCR: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9.3. Genomics Market for Microarray Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9.4. Genomics Market for Statistical Analysis: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9.5. Genomics Market for Bioinformatics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9.6. Genomics Market for DNA Sequencing: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9.7. Genomics Market for Others: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

16.10. Data Triangulation and Validation

17. MARKET OPPORTUNITIES BASED ON TYPE OF APPLICATION AREA
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Genomics Market for Diagnostics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.7. Genomics Market for Drug Discovery and Development: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.8. Genomics Market for Precision Medicine: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.9. Genomics Market for Agriculture & Animal Research: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.10. Genomics Market for Other Applications: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.11. Data Triangulation and Validation

18. MARKET OPPORTUNITIES BASED ON TYPE OF END USER
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Genomics Market for Clinical Research Institutes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.7. Genomics Market for Academic & Government Institutes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.8. Genomics Market for Hospitals & Clinics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.9. Genomics Market for Pharmaceutical & Biotechnology Companies: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.10. Genomics Market for Other End Users: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.11. Data Triangulation and Validation

19. MARKET OPPORTUNITIES FOR GENOMICS IN NORTH AMERICA
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix

19.6. Genomics Market in North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.1. Genomics Market in the US: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.2. Genomics Market in Canada: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.3. Genomics Market in Mexico: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

19.7. Data Triangulation and Validation

20. MARKET OPPORTUNITIES FOR GENOMICS IN EUROPE
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix

20.6. Genomics Market in Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.1. Genomics Market in Germany: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.2. Genomics Market in France: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.3. Genomics Market in Italy: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.4. Genomics Market in Spain: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.5. Genomics Market in the UK: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.6. Genomics Market in Rest of Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

20.7. Data Triangulation and Validation

21. MARKET OPPORTUNITIES FOR GENOMICS IN ASIA-PACIFIC
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. Genomics Market in Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.1. Genomics Market in China: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.2. Genomics Market in India: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.3. Genomics Market in Japan: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.4. Genomics Market in South Korea: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.5. Genomics Market in Australia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.6. Genomics Market in Russia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.7. Genomics Market in Thailand: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.8. Genomics Market in Malaysia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.9. Genomics Market in Indonesia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.10. Genomics Market in Rest of the Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR GENOMICS IN MIDDLE EAST AND NORTH AFRICA (MENA)
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. Genomics Market in Middle East and North Africa (MENA): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.1. Genomics Market in Egypt: Historical Trends (Since 2019) and Forecasted Estimates (Till 205)
22.6.2. Genomics Market in Saudi Arabia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.3. Genomics Market in United Arab Emirates (UAE): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. MARKET OPPORTUNITIES FOR GENOMICS IN LATIN AMERICA
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix

23.6. Genomics Market in Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
23.6.1. Genomics Market in Argentina: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
23.6.2. Genomics Market in Brazil: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

23.7. Data Triangulation and Validation

24. TABULATED DATA

25. LIST OF COMPANIES AND ORGANIZATIONS

26. CUSTOMIZATION OPPORTUNITIES

27. ROOTS SUBSCRIPTION SERVICES

28. AUTHOR DETAIL